| Literature DB >> 35541612 |
Huabing Zhao1, Sanyuan Shi1, Hong Zhao2, Jin Guo3, Zhen Yang3, Hongsheng Gao3, Fuping Lu1.
Abstract
Increasing attention has been paid to the toxicity and hazards of antibiotics on non-target organisms in soil ecosystems because redundant antibiotics in the excretion of treated animals are being brought into the soil by way of manure and sewage irrigation. In order to understand the toxic mechanisms of antibiotics in soil ecosystems, the earthworm Eisenia fetida was exposed to 500 mg kg-1 of oxytetracycline (OTC) as a typical antibiotic for 7, 14 and 21 days. The total proteins of E. fetida in each treatment were separated by two-dimensional gel electrophoresis and differential expressed proteins were identified by MALDI-TOF/TOF-MS. A total of 30 proteins were successfully identified and divided into four categories based on the function. It was surprisingly found that more than 50% of identified proteins belong to the actin family, and all of them were down-regulated more than 2.0-fold. In the meantime, the fibrinolytic enzymes, an important protease with plasminogen activator activity, were suppressed in the last two weeks. The validations in the mRNA level were performed using RT-PCR. However, due to the incomplete genome sequence of E. fetida, we failed to identify more proteins response to OTC stress. This study may provide a new insight into the discovery of novel biomarkers for continuous-poured and low-toxicity pollutants. This journal is © The Royal Society of Chemistry.Entities:
Year: 2019 PMID: 35541612 PMCID: PMC9076484 DOI: 10.1039/c9ra06004a
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Physical and chemical properties and the baseline of oxytetracycline in the tested soil
| Soil property | pH | OC | Sand | Silt | Clay | CEC | OTC |
|---|---|---|---|---|---|---|---|
| Tested soil | 8.18 | 18.85 g kg−1 | 36.99% | 28.91% | 34.10% | 16.33 cmol kg−1 | <0.001 mg kg−1 |
OC: organic matters content.
CEC: cation exchange content.
OTC: oxytetracycline.
Specific primer pairs for the two E. fetida genes used in this study
| Gene | Spots no. | Sense primer (5′–3′) | Antisense primer (5′–3′) |
|---|---|---|---|
| Actin | 5555 | CCGCCCTGGTCGTCGATAATG | TACCTCTCTTGCTCTGGGCCTCAT |
| β-Actin | — | TCTCCACCTTCCAGCAGATG | CGAAAAATGTCCTCCGCAAG |
The sequence of E. fetida actin gene was sequenced by the Beijing Genomics Institute.
Fig. 1Patterns of earthworm Eisenia fetida total proteins at 7, 14 and 21 days of OTC exposure stained by Coomassie Brilliant Blue R-250. 1 milligram of protein was used for IEF with linear IPG strips (pH 4–7) and for the second dimension vertical separation with 12.5% polyacrylamide gels. Blue Plus™ II Protein Marker purchased from TransGene (Beijing, China) was used as a molecular weight standard. The maps of control groups and OTC exposure groups were selected from three independent experiments.
The list of identified proteins using MALDI-TOF/TOF-MS and related information from the NCBI database
| Spot no. | NCBI GI. no. | Protein name (organism) | Theor. MW/pI | Exp. MW/pI | MASCOT score | SC |
|---|---|---|---|---|---|---|
|
| ||||||
| 6453 | gi|3319951 | Actin ( | 41.703/5.38 | 34.62/6.0 | 95 | 29 |
| 6306 | gi|3319951 | Actin ( | 41.703/5.38 | 30.24/5.8 | 98 | 36 |
| 3344 | gi|397881222 | Actin ( | 42.132/5.30 | 25.14/5.0 | 121 | 39 |
| 4113 | gi|1707573 | Actin ( | 42.161/5.30 | 19.65/5.3 | 155 | 38 |
| 6003 | gi|3046400 | Actin 1 ( | 8.257/5.48 | 12.95/5.8 | 81 | 79 |
| 5363 | gi|358332531 | Actin beta/gamma 1 ( | 35.711/5.04 | 28.33/5.4 | 144 | 57 |
| 3642 | gi|405964580 | Actin, cytoplasmic ( | 42.010/5.30 | 48.12/4.9 | 163 | 55 |
| 4014 | gi|3452277 | Beta actin ( | 14.537/5.28 | 13.26/5.4 | 84 | 60 |
| 9002 | gi|3452277 | Beta actin ( | 14.537/5.28 | 13.81/6.6 | 79 | 43 |
| 5260 | gi|197320840 | Beta-actin ( | 10.298/6.17 | 24.00/5.5 | 107 | 79 |
| 5555 | gi|2829750 | RecName: Full = actin ( | 41.582/5.46 | 45.50/5.6 | 159 | 40 |
| 5749 | gi|2829750 | RecName: Full = actin ( | 41.582/5.46 | 60.68/5.7 | 189 | 54 |
| 4117 | gi|2492669 | RecName: Full = actin, cytoskeletal 3; AltName: Full = LPC3 ( | 19.652/5.78 | 16.88/5.3 | 107 | 34 |
| 6313 | gi|1703136 | RecName: Full = actin, cytoskeletal; AltName: Full = M; flags: precursor ( | 42.063/5.30 | 32.36/5.9 | 134 | 42 |
| 4403 | gi|1703137 | RecName: Full = actin, cytoskeletal; AltName: Full = M; flags: precursor ( | 42.077/5.30 | 37.40/5.2 | 97 | 37 |
| 5024 | gi|27883553 | Alpha actin ( | 16.770/5.28 | 14.10/5.7 | 92 | 60 |
|
| ||||||
| 8401 | gi|16660643 | Fibrinolytic enzyme ( | 20.221/4.59 | 34.10/6.2 | 80 | 31 |
| 6203 | gi|110341195 | Fibrinolytic protease 0 ( | 23.588/5.31 | 24.79/5.8 | 88 | 40 |
| 9323 | gi|220924493 | GTP-binding protein EngA ( | 48.460/8.66 | 30.29/6.8 | 106 | 18 |
| 1107 | gi|61657939 | Myosin heavy chain, skeletal muscle, adult ( | 224.010/5.63 | 17.66/4.7 | 101 | 12 |
|
| ||||||
| 4301 | gi|268531882 | Hypothetical protein CBG02838 ( | 17.058/4.54 | 30.37/5.2 | 81 | 34 |
| 5558 | gi|436835559 | Hypothetical protein FAES_2173 ( | 7.091/6.07 | 38.70/5.7 | 93 | 50 |
| 5750 | gi|332017101 | Hypothetical protein G5I_14087 ( | 150.374/8.67 | 64.18/5.5 | 92 | 22 |
| 3434 | gi|395827452 | Predicted: ATP-dependent zinc metalloprotease YME1L1-like ( | 80.347/8.98 | 36.21/5.0 | 96 | 27 |
| 5364 | gi|530606293 | Predicted: dnaJ homolog subfamily C member 25-like ( | 42.272/9.10 | 25.98/5.6 | 84 | 33 |
| 6112 | gi|507644426 | Predicted: dolichyl-phosphate beta-glucosyltransferase isoform X2 ( | 33.609/9.34 | 20.55/5.8 | 84 | 33 |
| 3346 | gi|514704523 | Predicted: interleukin-17B isoform X3 ( | 21.123/9.35 | 29.33/4.8 | 90 | 50 |
| 2666 | gi|488526628 | Predicted: low quality protein: vinculin ( | 104.217/5.38 | 54.93/4.7 | 123 | 22 |
| 6550 | gi|488510571 | Predicted: protein phosphatase 1B isoform 2 ( | 26.106/5.11 | 38.88/5.9 | 83 | 32 |
| 7006 | gi|498969699 | Predicted: restin homolog isoform X7 ( | 202.861/4.99 | 14.16/6.1 | 94 | 19 |
| 5191 | gi|512836262 | Predicted: torsin-1A-interacting protein 2 isoform X9 ( | 15.666/6.88 | 16.75/5.4 | 80 | 35 |
The spot numbers are acquired from the PDQuest 8.0.1 software during analysis of 2-D gels.
The theoretical MW and pI are offered by the MASCOT search engine.
The experimental molecular mass (kDa) and pI are estimated from 2-DE gels according to their relative position.
Proteins identified are listed with the MASCOT score as a criteria for MS or MS/MS identification.
SC is short for sequence coverage.
Fig. 2Identification of spot 5555 via MALDI-TOF/TOF-MS. The protein excised from the gels was digested with trypsin and the peptides were analyzed by a MALDI-TOF/TOF ultraflex mass spectrometer (Bruker Daltonics). (A) MS spectra. The marked ion 976.493 was analyzed by MS/MS. (B) MS/MS spectra of ion 976.493.
The expression changes of the actin proteins up-/down-regulated
| Spot no. | Exposure time (day) | ||
|---|---|---|---|
| 7 | 14 | 21 | |
| 5555 | 1.14 | 1.12 | −2.22 |
| 5363 | 1.57 | −1.74 | −2.80 |
| 5260 | 1.65 | −2.03 | −1.84 |
| 4113 | 1.37 | 1.03 | −3.53 |
| 4117 | 3.46 | −1.71 | −2.54 |
| 5024 | 1.45 | −1.09 | −2.13 |
| 4014 | 2.11 | −1.50 | −2.54 |
| 6003 | 1.85 | −1.40 | −1.69 |
| 6453 | 2.17 | −2.41 | −2.54 |
| 6306 | 1.49 | −1.74 | −1.25 |
| 3642 | 2.81 | 1.57 | −2.06 |
| 4403 | 2.06 | −1.09 | −2.07 |
| 5749 | 1.57 | 0.00 | −2.09 |
| 9002 | 1.40 | 1.05 | −1.95 |
| 6313 | 1.70 | −1.69 | −1.55 |
| 3344 | 2.07 | −1.38 | −1.70 |
1.5 fold < the protein expression changes < 2.0 fold.
2.0 fold < the protein expression changes < 3.0 fold.
The protein expression changes > 3.0 fold.
Fig. 3The change trends of the Actin proteins expression ratio of treated group to control group at 7 days, 14 days and 21 days. The areas outside the dashed line indicate the ratio is more than 1.5; Texp means protein expression of treated group; CKexp means protein expression of control group.
Fig. 4The mRNA expression changes of actin gene during the exposure time of 7 days, 14 days and 21 days under the oxytetracycline stress. The comparation between treatment groups and control group was performed using the 2−ΔΔ method (Livak and Schmittgen, 2001).
Fig. 5The expression fold changes of the fibrinolytic enzymes at 7 days, 14 days and 21 days compared with respective control groups. Texp means protein expression of treated group; CKexp means protein expression of control group.